Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.77M$7.77Mderived+14.1% vs Q4 2023 Net Income-$5.39M-$5.39MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$4,762,000+18.7% Operating Incomederived-$5,636,000N/M Operating Cash Flowderived-$1,243,000N/M Free Cash Flowderived-$1,506,000N/M Margins · derivedGross margin61.3%+2.4 pt vs Q4 2023
Operating margin-72.5%−3.4 pt vs Q4 2023
Net margin-69.3%−1.5 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d after period end